Liquid Biopsy

Sensitivity and coverage for cfDNA samples

Liquid biopsy research studies require sensitivity. The MassARRAY^® System can detect variants as low as 0.1% allele frequency at a low cost, making it ideally suited for detecting low abundance mutations.

While liquid biopsies provide easier access to tumor cells and DNA, they don’t necessarily provide enough. With just a few copies of circulating tumor DNA (ctDNA) per mL of plasma, you cannot afford to run multiple tests to detect all emerging resistance markers. The multiplexing capability of the UltraSEEK^® chemistry makes it easy to detect over 100 variants, including insertions and deletions, using cfDNA from a single blood draw.